MARÍA JESÚS OSET GASQUE-rekin lankidetzan egindako argitalpenak (6)

2017

  1. Corrigendum: Melatonin and nitrones as potential therapeutic agents for stroke [Front. Aging Neurosci., 8 (2016) (281)] DOI:10.3389/fnagi.2016.00281

    Frontiers in Aging Neuroscience

2016

  1. Melatonin and nitrones as potential therapeutic agents for stroke

    Frontiers in Aging Neuroscience, Vol. 8, Núm. NOV

2014

  1. Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9, 10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 74, pp. 491-501

2013

  1. Nontoxic and neuroprotective β-naphthotacrines for alzheimer's disease

    Chemical Research in Toxicology, Vol. 26, Núm. 6, pp. 986-992

  2. Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer's disease

    Bioorganic and Medicinal Chemistry Letters, Vol. 23, Núm. 7, pp. 1916-1922

2012

  1. Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 54, pp. 750-763